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Abstract 
BACKGROUND: Aging is an increasing concern of modern society, particularly facial ageing. In recent years, the 
microinjection technique has increasingly been emphasised as a skin rejuvenation strategy. Hyaluronic acid (HA) 
plays an important role in the hydration of the extracellular space and can thus improve skin hydration, firmness 
and viscoelastic properties.  
AIM: To evaluate the efficacy and safety of HA microinjection in skin rejuvenation. 
METHODS: We enrolled thirty participants underwent three sessions of HA microinjection involving multiple 
injections in the face or back of the hands at 2-week intervals. The aesthetic outcomes were assessed at baseline 
and after 2, 4 and 8 weeks. Clinical evaluation was based on the Global Aesthetic Improvement Scale (GAIS) and 
the Wrinkle Severity Rating Scale (WSRS).  
RESULTS: Evaluation of photographs from 2, 4 and 8 weeks revealed significant clinical improvement in the 
brightness, texture and wrinkling of the skin. Analysis of the GAIS and WSRS scores revealed statistically 
significant results after 2 months.  
CONCLUSION: Most of the participants felt satisfied with the treatment (93.3%). 
 
 
 
 
 
 
 
 
Introduction 
 
Ageing is an increasing concern of modern 
society, particularly facial ageing. This complex 
process involves two important factors: volume loss in 
the face and repetitive muscle movements resulting in 
wrinkles and folds. In recent years, the technique of 
intradermal microinjection with pharmacologic 
substances has been emphasised in skin 
rejuvenation.  
This technique aims to restore or maintain 
youthful and healthy skin structures. The desired 
effect is firm, bright and moisturised skin via injection 
of appropriate, completely biocompatible and easily 
absorbable products into the superficial dermis. 
Among the skin rejuvenation microinjection products, 
hyaluronic acid (HA) plays an important role in 
hydration of the extracellular space due to its ability to 
attract water molecules, and HA is thought to give 
physiological conditions conducive to extracellular 
matrix production [1], [2]. 
Some clinical experiments have shown that 
HA microinjection can stimulate fibroblasts to express 
collagen type 1 (Col-1), matrix metalloprotease-1 
(MMP-1), and tissue inhibitor of matrix 
metalloproteinase-1 (TIMP) [2], [3], [4]. This technique 
is safe when conducted by well-trained 
dermatologists. However, there have been few clinical 
studies on HA microinjection in Vietnam. We 
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conducted this study to evaluate the safety and 
efficacy of HA microinjection in skin rejuvenation. 
 
 
Subjects and Methods 
 
This open clinical study was carried out at the 
HCMC Hospital of Dermato-Venereology. Thirty 
participants were enrolled in the study from October 
2014 to October 2015. The inclusion criteria were as 
follows: healthy participants who presented with 
mild/moderate to severe photoaging and were not 
using any other treatments. Exclusion criteria included 
previous use of other medical-aesthetical treatments; 
any cutaneous pathology of infectious, inflammatory, 
viral and vascular type affecting the face; history of 
coagulation disorders; wound healing disorders; 
history of allergy to HA or any ingredient of the test 
product; and women who were pregnant or 
breastfeeding. All participants gave informed consent 
for enrollment in the clinical study. 
All participants underwent three sessions of 
mesotherapy involving multiple microinjections with a 
30 G/4 mm needle in the face or back of the hand at 
2-week intervals. The study was conducted for 2 
months. The photographic evaluation was performed 
at each treatment and 1 month later after the last 
session. The results were defined with a score derived 
from the Global Aesthetic Improvement Scale (GAIS), 
which was used as a reference parameter (Table 1).  
Table 1: Global Aesthetic Improvement Scale (GAIS) 
 Degree  Description  
1 Exceptional improvement The excellent corrective result after a session with the 
VISIA device 
2 Very improved patient Marked improvement in appearance, but not completely 
optimal. A touch-up would slightly improve the result 
3 Improved patient Improvement in appearance to better than the initial 
condition, but a touch-up is advised 
4 Unaltered patient The appearance remains substantially the same as the 
original condition 
5 Worsened patient The appearance has become worse than the original 
condition 
 
Moreover, the Wrinkle Severity Rating Scale 
(WSRS) was used to evaluate the condition of the 
wrinkles and, therefore, the degree of ageing (Table 
2). The participants were also asked for self-
assessment of improvement. 
Table 2: Wrinkle Severity Rating Scale (WSRS) 
Score  Description  
1 Absent  
2 Slight  
3 Moderate  
4 Severe  
5 Extreme  
 
 
 
Results 
 
A total of 30 women aged 30-65 years (mean 
age 46 years) were included in the study. Two 
participants were lost to follow-up after the first 
treatment. We had fourteen participants aged 41-50 
years (46.7%), which was the most common age 
group seeking treatment. Most of the participants had 
significant improvement after the first treatment (50%), 
and the improvement continued to increase after the 
second (70%) and third treatments (83.3%), as 
indicated by the GAIS evaluation. 
The difference between the GAIS scores at 
weeks 4 and 2 was not clinically significant. However, 
the improvement between week 8 and week 2 was 
clinically significant (p < 0.05). 
At all evaluation time points, the participants 
showed a significant improvement in their skin status 
compared with that at baseline (p < 0.01) as shown in 
Figure 1.  
 
Figure 1: Wrinkle Severity Rating Scale (WSRS) before (WSRS0), 
after 2 weeks (WSRS2), 4 weeks (WSRS4) and 8 weeks (WSRS8). 
* Comparisons of WSRS2, WSRS4 and WSRS8 to WSRS0 
indicated statistically significant differences (p < 0.01) 
 
Adverse effects were generally of mild or 
moderate intensity and expected (pain, oedema, 
petechia, hematoma or dark eye circle). The most 
common expected adverse event was a pain (53.3%), 
followed by oedema (40%) and petechia (26.7%). 
Among 30 participants, 23 (76.6%) felt 
satisfied with the result. Moreover, 5 (16.7%) felt very 
satisfied with the treatment. 
 
 
Discussion 
 
This clinical, open study with 30 participants 
demonstrated the efficacy of HA microinjection in skin 
rejuvenation. Most of the participants were aged 41-
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50 years, which is consistent with the studies 
conducted by Adele Sparavigna in 2015 (64 patients 
aged 37-60 years) [3], and Antonella in 2013 (50 
patients) [4]. From 30 years of age, skin renewal 
decreases, so the very first signs of ageing become 
visible, such as uneven skin tone, wrinkles, unhealthy 
skin and elastin degeneration, resulting in decreased 
skin firmness. Therefore, this is the age when patients 
start to seek skin rejuvenation procedures. 
Most of the participants had significant 
improvement after the first treatment and continued to 
improve after every subsequent session. In our study, 
this significant effect of HA mesotherapy on skin 
elastic properties and wrinkles was coupled to a 
sustained improvement after the last session. This 
finding is consistent with the study of Antonella 
conducted in Italy. To investigate the molecular effects 
on the skin caused by HA treatment, the authors 
analysed the expression levels of IL-6, IL-1b, MMP-1, 
and Col-1 at the beginning and end of the treatment 
using immunohistochemistry. The authors observed a 
decrease in IL-1β, IL-6 and MMP-1 levels and an 
increase in Col-1 levels. These results were 
statistically analysed and showed that treatment 
resulted in significant and long-lasting rejuvenation 
effects. These data were confirmed both subjectively 
and objectively by GAIS and WSRS score analysis 
(50 patients) [4]. 
Furthermore, HA microinjection can improve 
skin hydration, firmness and viscoelastic properties. 
These benefits were proven by Martine Baspeyras et 
al. when the authors conducted a study to evaluate 
the effect of microinjection of HA by histology and 
electron microscopy examination of skin biopsies. The 
results showed significant improvement after 
treatment with p < 0.01 [2]. 
Adele Sparavigna et al. reported a statistically 
significant improvement in profilometric parameters, 
skin brightness, pigmentation, and deep skin 
hydration when treating skin ageing and photoaging 
with HA microinjection in clinics (p < 0.05) [3]. 
Intradermal HA injection will stimulate 
fibroblasts, increase the collagen, elastin and HA 
synthesis in the treatment area, and promote 
extracellular matrix production and epithelial 
regeneration, resulting in skin rejuvenation [5]. 
WSRS2, WSRS4, and WSRS8 exhibited 
statistically significant differences compared with 
WSRS0. The improvement in wrinkles was observed 
after the first treatment and increased after every 
session. 
The efficacy of revitalization in skin 
rejuvenation was confirmed by the study of Adela 
Sparavigna et al. [3]. This study demonstrated the 
improvement in at least one grade of crow’s feet, and 
the efficacy was found not only on the face but also on 
the décolletage and hand skin surface [3]. 
The new minimally invasive mesotherapy 
technique with HA can improve the clinical 
appearance of the skin in different age groups, as 
reported in a study conducted by Antonella et al. in 
Italy. This study demonstrated a significant and long-
lasting effect on the brightness, texture, and firmness 
of the skin [4]. More interesting, HA microinjection 
also resulted in skin hydration, not only at the 
superficial level but also in the deep layers of the skin. 
This study showed that HA could have acted as a 
water content modulator in the skin layers, thus 
improving the epidermal barrier function, which is 
often affected by the ageing mechanism [3]. 
The most common side effects included pain, 
oedema, petechia, and hematoma. However, those 
side effects lasted for only three to four days and were 
completely tolerable by the participants. Martine 
Baspeyras et al. also showed some common adverse 
events, including hematoma, oedema, papule and 
erythema. All expected adverse events disappeared 
within a mean time of 5.9 days [2], [7]. 
Most of the participants felt satisfied or very 
satisfied with the treatment (93.3%). These data 
indicate that this technique is efficacious and safe and 
can be well tolerated by customers. 
In conclusion, this study objectively 
demonstrated the efficacy and safety of HA 
microinjection for skin rejuvenation. In particular, we 
showed that intradermal HA mesotherapy might be of 
value to decrease the wrinkles and increase the 
suppleness of ageing skin when conducted by a 
trained physician. The improvement started from the 
first treatment and continued to increase after every 
session. Most of the participants felt satisfied or very 
satisfied with the treatment (93.3%). Adverse events 
included pain, oedema, petechia, and hematoma, but 
these effects lasted for three to four days only and 
were completely tolerable. 
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